Qt Imaging Holdings (QTI) Net Cash Flow Growth (3y) (2024 - 2026)
Qt Imaging Holdings (QTI) Net Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.82 Bn | 176.53 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.59 Bn | 67.14 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.11 Bn | 25.82 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.28 Bn | 21.15 Bn | 2.07 Bn | -48.90% |
| 10 | Qt Imaging Holdings | 37.94 Mn | 31.04 Mn | 2.67 Mn | -32.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.82% |
| Dec 31, 2025 | 185.69% |
| Sep 30, 2025 | -1.58% |
| Jun 30, 2025 | -91.78% |
| Mar 31, 2025 | 114.83% |
| Dec 31, 2024 | 38.86% |
| Sep 30, 2024 | -26.26% |
| Mar 31, 2024 | 394.15% |